Glen Industries Current Share Price | Glen Industries Stock Screener
GLEN
Pharmaceuticals
Glen Industries Current Stock Price Today
Track the current Glen Industries share price and stock price live with TickJournal's free stock screener.
Explore GLEN dividend growth and follow the dividend payout track record.
Use the Glen Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Glen Industries Market Cap
₹286.31 Cr.
GLEN P/E Ratio (TTM)
-
Glen Industries P/B Ratio
2.12
EPS (TTM)
₹6.86
Dividend Yield
-
Debt to Equity
1.28
GLEN 52 Week High
-
Glen Industries 52 Week Low
-
Operating Margin
-
Profit Margin
-
GLEN Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹291.00
Total Equity
₹140.00
Glen Industries Current Share Price Chart
Track the current Glen Industries share price and stock price with an interactive chart. Analyse GLEN price trends, trading volume, historical performance, and volatility across different timeframes — the complete Glen Industries stock quote in one place.
Glen Industries Company Profile - Fundamental Screener
Screen Glen Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GLEN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0UMC01019
Glen Industries Balance Sheet Screener
Screen GLEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 291 | 214 | 161 | 137 | 116 |
| Current Assets | 169 | 104 | 78 | 62 | 58 |
| Fixed Assets | 109 | 108 | 81 | 73 | 55 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 30 | 56 | 40 | 41 | 41 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 140 | 59 | 46 | 36 | 23 |
| Share Capital | 32 | 18 | 6 | 6 | 6 |
| Reserves & Surplus | 107 | 41 | 40 | 31 | 17 |
Glen Industries Income Statement Screener - Profit & Revenue Analysis
Screen Glen Industries income statement and profit fundamentals.
Analyze GLEN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Glen Industries share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|---|
| Revenue | 0 | 205 | 171 | 145 | 120 | 97 |
| Expenses | 0 | 166 | 130 | 120 | 103 | 83 |
| EBITDA | 0 | 39 | 41 | 25 | 17 | 14 |
| Operating Profit % | 0.00% | 18.00% | 24.00% | 17.00% | 14.00% | 12.00% |
| Depreciation | 0 | 8 | 7 | 6 | 6 | 5 |
| Interest | 0 | 9 | 9 | 7 | 6 | 4 |
| Profit Before Tax | 0 | 22 | 24 | 11 | 3 | 5 |
| Tax | 0 | 5 | 6 | 3 | 1 | 1 |
| Net Profit | 0 | 17 | 18 | 9 | 2 | 4 |
| EPS | 0.00 | 6.86 | 10.39 | 82.42 | 0.85 | 2.09 |
Glen Industries Cash Flow Screener - Liquidity Fundamentals
Screen GLEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
| Operating Activities | 6 | 6 | 14 | 11 | -14 |
| Investing Activities | -18 | -35 | -13 | -15 | -22 |
| Financing Activities | 11 | 30 | -2 | 4 | 34 |
| Net Cash Flow | -1 | 1 | -1 | 0 | -2 |
Glen Industries Shareholding Pattern Screener
See Glen Industries shareholding pattern with promoter, FII, and DII holdings.
Check Glen Industries promoter holding and ownership changes for GLEN on TickJournal.
| Item | 2026-Mar | 2025-Jun | 2025-Jul | 2025-Sept | 2024-Dec |
|---|---|---|---|---|---|
| Promoter Holding | 73.31% | 73.00% | 73.00% | 73.00% | 100.00% |
| FII Holding | 0.00% | 1.83% | 1.83% | 0.22% | 0.00% |
| DII Holding | 6.64% | 9.93% | 9.93% | 9.06% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.47% | 11.95% | 11.95% | 12.31% | 0.00% |
| Other Holding | 4.57% | 3.29% | 3.29% | 5.41% | 0.00% |
| Shareholder Count | 1,118 | 1,267 | 7 | 1,196 | 7 |
Glen Industries Share Dividend Screener - Share Yield Analysis
Check Glen Industries dividend history with payout and yield data.
View Glen Industries dividend details including ex-dates and amounts for GLEN stock.
Glen Industries Stock Index Membership
See which indices include Glen Industries stock.
Check GLEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Glen Industries Market Events Screener - Corporate Actions
Get Glen Industries corporate actions including splits, bonuses, and buybacks.
Check Glen Industries stock events that may affect GLEN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-20 | 2026-08-20 | Annual General Meeting | NA | 52.42% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | 4.56% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 0.95% |
| 2025-09-22 | 2025-09-22 | Annual General Meeting | NA | -5.52% |
Glen Industries Competitors Screener - Peer Comparison
Screen GLEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,899 | 37.28 | 61,674 | 12.69% | 11,565 | 33.60 |
| Divis Laboratories | 227,984 | 77.10 | 11,067 | 13.95% | 2,568 | 74.07 |
| Torrent Pharmaceuticals | 189,081 | 86.36 | 13,886 | 20.34% | 2,138 | 54.91 |
| Cipla | 115,611 | 34.42 | 29,045 | 2.24% | 3,870 | 44.38 |
| Zydus Life Science | 112,255 | 24.59 | 27,658 | 17.64% | 5,026 | 46.32 |
| Lupin | 102,054 | 18.61 | 29,039 | 26.75% | 5,356 | 32.17 |
| Dr Reddys Laboratories | 98,391 | 31.25 | 35,059 | 3.90% | 4,158 | 43.27 |
| Mankind Pharma | 98,293 | 47.94 | 14,636 | 14.85% | 1,938 | 38.61 |
| Laurus Labs | 97,930 | 89.15 | 6,868 | 22.01% | 890 | 64.93 |
| Aurobindo Pharma | 94,650 | 25.43 | 34,145 | 5.56% | 3,503 | 59.26 |
Glen Industries Company Announcements - News Screener
Screen GLEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-18 | Regulation 32 Monitoring Agency Report | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-07-31 | Outcome Of Analyst/ Institutional Investor Meeting Held On July 30 2026 & July 31 2026 | - |
| 2026-07-29 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-07-29 | Annual General Meeting Of The Members Of The Company And Cut-Off Date | - |
| 2026-07-29 | Newspaper Clippings - 19Th Annual General Meeting Of The Members Of The Company And Other Related Information | - |
| 2026-07-28 | Shareholding Meeting Of The Company To Be Held On 20Th August 2026 For The Year Ended 2025-26 | - |
| 2026-07-28 | Reg. 34 (1) Annual Report. | - |
| 2026-07-28 | Annocement Under Regulation 30 (LODR) - Updates (Notice Of The 19 Th Annual General Meeting And Annual Report For The FY 2025-26) | - |
| 2026-07-27 | Outcome Of The Board Meeting | - |
| 2026-07-27 | Investor Meeting Is Scheduled To Be Held On 30 Th & 31St July In Mumbai Maharashtra . | - |
| 2026-07-16 | Quarterly Commentary - Standalone Sales Performance And Project Progress Update | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Intimation Under Regulation 30 Read With Schedule III Part A And Para B Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |